Though they are still primarily prescribed for weight loss and diabetes, researchers are looking at the effects of GLP-1s for a wide variety of conditions from substance abuse dis ...

Just weeks after forming as a spinout from Endevica Bio, obesity drug developer Kalohexis has filed for an IPO, whilst ...

Island Pharma has been granted the regulatory approvals needed to allow compassionate use of its antiviral galidesivir in the ...

Women with endometriosis in England could soon be offered simple non-invasive tests for diagnosis of their condition, rather ...

Vertex Pharma has made the largest acquisition in its history, agreeing to buy Crinetics Pharma for around $10 billion in a ...

After losing its measles elimination status earlier this year, the UK has launched a campaign urging around a million ...

Let me start with something most strategy decks dance around: the patent cliff isn't the problem. It's the symptom. Every ...

As practising oncologists, we've seen firsthand how a cancer diagnosis changes the way patients engage with information.

For more than a century, tissue biopsies have stood as the gold standard for diagnosing cancer. And for good reason. These tiny tumour samples can unlock a wealth of molecular information, information ...

This month, the European Commission granted centralised marketing authorisation for Zandoriah (teriparatide), a biosimilar to ...

The NHS will include an AI-powered triage tool in the NHS App in an attempt to cut waiting lists and improve care for ...

Roche's Genentech unit has forged an alliance with Astex, worth up to $515 million, to partner on a fragment-based drug ...